Clinical Trial Update: A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the effect of exenatide on mean 24-hour heart rate in adults with Type 2 Diabetes Mellitus were posted on June 12, 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2009-06-12